Using genetic engineering to enhance silk proteins for medical uses
Leveraging biodiversity and utilizing genetic engineering to expand the structure and function of silk fibroin biopolymers for biomedical applications
This study is looking at ways to make silk proteins from silkworms even better for use in healthcare, so that patients can benefit from improved medical devices and treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10876322 on NIH RePORTER |
What this research studies
This research focuses on improving silk fibroin biopolymers, which are natural proteins derived from silkworms, for applications in healthcare. By utilizing genetic engineering techniques like CRISPR, the researchers aim to modify the structure and function of these proteins to create more effective materials for medical use. The project seeks to overcome limitations of both synthetic and naturally derived polymers by enhancing the customizability and biocompatibility of silk fibroin. Patients may benefit from new medical devices or treatments developed from these advanced materials.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals requiring advanced medical treatments or devices that utilize biocompatible materials.
Not a fit: Patients with conditions that do not require the use of biopolymers or advanced medical materials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of innovative medical materials that are safer and more effective for patient care.
How similar studies have performed: While genetic engineering of silk proteins has been attempted with limited success, this approach is still relatively novel and untested on a larger scale.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Stoppel, Whitney L — University of Florida
- Study coordinator: Stoppel, Whitney L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.